{
  "schemaVersion": 2,
  "eyebrow": "Dermatology",
  "title": "Tinea Pedis",
  "summary": "Confirm atypical, chronic, or treatment-refractory foot eruptions with potassium hydroxide examination, then match topical therapy duration to interdigital versus hyperkeratotic disease. Escalate persistent disease by reassessing diagnosis, nail reservoir, adherence, immunologic risk, bacterial superinfection, and need for culture-directed evaluation.",
  "seoDescription": "Physician guide to diagnosing and treating tinea pedis, including KOH testing, topical antifungal selection, refractory disease, and recurrence prevention.",
  "clinicalQuestion": "How should clinicians confirm, treat, and prevent recurrent or refractory tinea pedis?",
  "specialty": "Dermatology",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "tinea pedis",
    "athlete's foot",
    "interdigital tinea pedis",
    "moccasin tinea pedis",
    "KOH preparation",
    "dermatophyte infection",
    "terbinafine"
  ],
  "keyTakeaways": [
    "Use potassium hydroxide examination of scale when the morphology is atypical, disease is hyperkeratotic, or treatment has failed; branching hyphae support dermatophyte infection. [2][4][6][15]",
    "For limited disease, topical terbinafine 1% twice daily for 1-2 weeks is a supported first-line regimen; miconazole requires 3-4 weeks. [22]",
    "Interdigital disease may respond within 1 week, whereas hyperkeratotic moccasin-type disease commonly requires about 4 weeks because keratin limits topical penetration. [11][12][15]",
    "For refractory disease, obtain fungal culture, examine and address concomitant onychomycosis, and reassess for bacterial toe-web infection, immune deficiency, resistance, or an alternative inflammatory diagnosis. [12][17][20]",
    "Avoid nystatin for tinea pedis because it is ineffective against dermatophytes. [11]"
  ],
  "sections": [
    {
      "id": "triage-and-clinical-pattern",
      "eyebrow": "Initial assessment",
      "heading": "Identify the pattern that changes testing and treatment duration",
      "intro": "Classify the distribution before selecting a regimen or assuming treatment failure.",
      "paragraphs": [
        "Interdigital tinea pedis typically presents in toe webs, while hyperkeratotic disease produces chronic scaly erythema across the plantar and lateral foot in a moccasin distribution. Vesicular or bullous disease may involve the sole. Hyperkeratotic disease is frequently associated with interdigital involvement and may extend from the toes across the plantar surface. [2][15]",
        "A painful, macerated, malodorous, or persistently erosive toe web should not be managed as uncomplicated dermatophyte infection alone. Refractory toe-web disease can reflect inadequate treatment, concomitant nail disease, antifungal or antibiotic resistance, or immune deficiency; reassess these branches rather than simply extending empiric topical therapy. [12]",
        "Examine both feet, all interdigital spaces, and toenails at the initial visit. Concurrent onychomycosis can serve as a persistent reservoir and is specifically identified as a contributor to refractory toe-web infection. [12]"
      ],
      "bullets": [
        "Favor hyperkeratotic tinea pedis when plantar scale and erythema cover the sole while sparing the dorsum. [15]",
        "Consider inflammatory or bullous tinea pedis when vesicles or bullae are present; demonstrate hyphae with KOH when possible. [2][3]",
        "Reconsider the diagnosis when plantar erythema is diffuse or treatment-resistant: relevant alternatives include intertrigo, cellulitis, atopic dermatitis, contact dermatitis, eczema, juvenile plantar dermatosis, mycosis fungoides, and pityriasis rubra pilaris. [15]"
      ],
      "subsections": [],
      "table": {
        "caption": "Clinical pattern directs expected response time and diagnostic confirmation. [2][15]",
        "columns": [
          "Pattern",
          "Key distribution clue",
          "Actionable next step"
        ],
        "rows": [
          [
            "Interdigital",
            "Pruritic, erythematous, inflamed toe-web disease. [2]",
            "Treat with a topical antifungal; improvement may occur within 1 week. [11][15]"
          ],
          [
            "Hyperkeratotic moccasin type",
            "Chronic scaly plantar erythema involving soles and lateral feet, often sparing the dorsum. [2][15]",
            "Perform KOH when available; use a longer topical course, typically about 4 weeks. [12][15]"
          ],
          [
            "Vesicular or bullous",
            "Vesicles or bullae on the sole. [2]",
            "Obtain KOH from active scale or lesion material to document dermatophyte infection. [2][3]"
          ],
          [
            "Refractory toe-web eruption",
            "Persistent disease despite treatment, especially with nail involvement or maceration. [12]",
            "Culture for fungus; evaluate for bacterial infection, resistance, immune deficiency, and nonfungal mimics. [12][17]"
          ]
        ]
      }
    },
    {
      "id": "diagnostic-testing",
      "eyebrow": "Confirmation",
      "heading": "Use KOH and culture when the result will redirect management",
      "intro": "Testing is most valuable when morphology, severity, or treatment response makes clinical diagnosis unreliable.",
      "paragraphs": [
        "Perform a potassium hydroxide preparation from scale at the active edge or involved toe web when hyperkeratotic disease must be distinguished from inflammatory dermatoses, when bullous disease is suspected, or when prior treatment has failed. Identification of bright linear branching hyphae supports dermatophyte infection. [4][6][15]",
        "Clinical diagnosis is often used when KOH is unavailable, but a negative or unavailable bedside test should not indefinitely sustain a diagnosis of tinea in chronic disease. In chronic or recurrent dermatophytosis and when antifungal resistance is suspected, order fungal culture; culture and serial cultures may also help establish mycologic cure in selected patients. [8][17]",
        "If a topical corticosteroid has altered lesion morphology, consider tinea incognito. Look for residual scaly erythematous edges, obtain KOH, and culture chronic, recurrent, or potentially resistant disease. Polymerase chain reaction and matrix-assisted laser desorption ionization-time-of-flight are emerging higher-sensitivity approaches where available. [17]"
      ],
      "bullets": [
        "Positive KOH: treat as dermatophyte infection and match duration to clinical pattern. [4][6][12][15]",
        "Persistent disease after an appropriate topical course: obtain fungal culture rather than repeating empiric antifungal cycles. [12][17]",
        "Follicular papules, pustules, or nodules within a longstanding plaque raise concern for Majocchi granuloma; histopathology is required for conclusive diagnosis. [17]"
      ],
      "subsections": [],
      "table": {
        "caption": "Testing strategy for suspected or refractory tinea pedis. [8][12][17]",
        "columns": [
          "Clinical situation",
          "Test",
          "Interpretation and management consequence"
        ],
        "rows": [
          [
            "Typical limited interdigital eruption",
            "Clinical diagnosis may be used; KOH if uncertainty is meaningful. [8][15]",
            "Treat localized disease with a topical antifungal and reassess if it persists. [11][22]"
          ],
          [
            "Moccasin-type or atypical plantar scale",
            "KOH preparation from involved scale. [4][6][15]",
            "Branching hyphae support dermatophyte infection and help distinguish it from inflammatory plantar dermatoses. [6][15]"
          ],
          [
            "Chronic, recurrent, or suspected resistant disease",
            "Fungal culture. [17]",
            "Use the result to confirm dermatophytosis and investigate resistance or an alternative diagnosis when response is inadequate. [12][17]"
          ],
          [
            "Perifollicular papules, pustules, or nodules",
            "Histopathology. [17]",
            "Required to establish Majocchi granuloma, which should not be managed as superficial tinea alone. [17]"
          ]
        ]
      }
    },
    {
      "id": "topical-treatment",
      "eyebrow": "First-line treatment",
      "heading": "Treat limited tinea pedis with topical antifungal therapy",
      "intro": "Drug choice matters less than adequate coverage, duration, and extension beyond visible disease.",
      "paragraphs": [
        "For nonextensive tinea pedis, use terbinafine 1% cream or gel twice daily for 1-2 weeks. Miconazole is an alternative topical regimen applied for 3-4 weeks. A broad evidence base supports topical antifungals over placebo, and terbinafine or naftifine may provide slightly higher cure rates than azoles. [11][22]",
        "Apply cream or powder 1-2 cm beyond visible disease and continue for 1 week after apparent clinical resolution. For hyperkeratotic plantar disease, a 2-3 week or 4-week course may be needed; the longer duration reflects the barrier imposed by thick keratinized skin. [12][15]",
        "Luliconazole 1% is an FDA-approved topical option for interdigital tinea pedis. In pivotal trials, participants applied it once daily for 14 days to the entire forefoot, all interdigital spaces, and approximately 2.5 cm of surrounding skin; outcomes were assessed 4 weeks after treatment. [1]"
      ],
      "bullets": [
        "Interdigital disease: topical therapy may require only 1 week, depending on the agent and response. [11][15]",
        "Hyperkeratotic moccasin disease: plan approximately 4 weeks of topical therapy rather than judging failure after a short interdigital-course regimen. [12][15]",
        "Do not use nystatin for dermatophyte tinea pedis. [11]",
        "Avoid topical antifungal-corticosteroid combinations when possible because corticosteroid exposure can produce atypical tinea incognito and delay diagnosis. [11][17]"
      ],
      "subsections": [
        {
          "heading": "When to consider oral treatment",
          "paragraphs": [
            "Consider oral therapy for severe, chronic, or topical-treatment-refractory tinea pedis. Oral itraconazole or terbinafine are identified options for these circumstances; before escalation, obtain fungal culture in chronic or recurrent disease and evaluate untreated onychomycosis, adherence, bacterial toe-web infection, and alternative diagnoses. [17][20]"
          ],
          "bullets": [
            "Avoid reflexive systemic escalation for a short course failure in hyperkeratotic disease; first confirm that topical treatment duration and application were adequate. [12][15]",
            "When nail disease is present, treat the overall dermatophyte burden rather than repeatedly treating the foot alone. [12][20]"
          ]
        }
      ],
      "table": {
        "caption": "Topical regimens and duration should be matched to disease pattern. [1][11][12][15][22]",
        "columns": [
          "Option",
          "Source-supported regimen",
          "Best use or limitation"
        ],
        "rows": [
          [
            "Terbinafine 1%",
            "Cream or gel twice daily for 1-2 weeks. [22]",
            "First-line option for nonextensive tinea; allylamines may have slightly higher cure rates than azoles. [11][22]"
          ],
          [
            "Miconazole",
            "Topical treatment for 3-4 weeks. [22]",
            "Alternative for nonextensive tinea when a longer treatment course is acceptable. [22]"
          ],
          [
            "Luliconazole 1%",
            "Once daily for 14 days; cover entire forefoot, toe webs, and approximately 2.5 cm surrounding area. [1]",
            "FDA-labeled option for interdigital tinea pedis. [1]"
          ],
          [
            "Any effective topical antifungal",
            "Extend 1-2 cm beyond visible disease and continue 1 week after apparent resolution. [12]",
            "For hyperkeratotic disease, treatment may need 2-4 weeks. [12][15]"
          ]
        ]
      }
    },
    {
      "id": "refractory-recurrent-disease",
      "eyebrow": "Escalation",
      "heading": "Work up apparent treatment failure before repeating therapy",
      "intro": "Failure usually reflects an incorrect diagnosis, untreated reservoir, inadequate exposure, or complicating infection.",
      "paragraphs": [
        "At follow-up, determine whether the initial regimen reached all involved toe webs and plantar surfaces and whether treatment continued beyond visible resolution. For hyperkeratotic disease, an apparent early failure may simply represent insufficient duration because topical penetration is limited by keratinization. [12][15]",
        "If disease is recurrent or persists after an adequate course, perform fungal culture and inspect for onychomycosis. Nail involvement, immune deficiency, and antifungal or antibiotic resistance are recognized contributors to refractory toe-web infection. [12][17]",
        "When toe webs are macerated or otherwise clinically concerning for bacterial involvement, evaluate for mixed infection rather than treating dermatophytes in isolation. Dermatophyte-associated barrier disruption can precede interdigital toe-web infection, and bacterial cultures from interdigital spaces in patients with tinea pedis have recovered potentially pathogenic organisms, commonly group A beta-hemolytic streptococci. [12][21]"
      ],
      "bullets": [
        "Culture chronic or recurrent disease and suspected resistance. [17]",
        "Assess for tinea incognito if topical corticosteroids have been used or lesion borders are atypical. [17]",
        "Biopsy follicular papules, pustules, or nodules when Majocchi granuloma is possible. [17]",
        "Address concomitant onychomycosis when recurrent pedal disease suggests a nail reservoir. [12][20]"
      ],
      "subsections": [
        {
          "heading": "Prevent recurrence and reduce cellulitis risk",
          "paragraphs": [
            "For recurrent tinea pedis, direct prevention toward restoration of toe-web barrier integrity and treatment of persistent reservoirs. Topical antifungals or powders applied beyond visible disease and continued after clearance are used to reduce residual dermatophyte burden; prophylactic antifungals can reduce recurrence. [12]",
            "Control recurrent tinea pedis in patients with recurrent lower-extremity cellulitis. Chronic or recurrent dermatomycosis, including tinea pedis and onychomycosis, is associated with recurrent cellulitis, and foot hygiene should specifically include interdigital web spaces. [21]"
          ],
          "bullets": [
            "Consider urea cream when thick plantar skin is a suspected recurrent reservoir; use a lower concentration for thin toe-web skin. [12]",
            "In diabetes, optimize glycemic control as part of recurrence-risk management for fungal skin infection and cellulitis. [21]"
          ]
        }
      ],
      "table": {
        "caption": "Actions for persistent or recurrent tinea pedis. [12][17][20][21]",
        "columns": [
          "Problem at reassessment",
          "Immediate action",
          "What changes next"
        ],
        "rows": [
          [
            "Hyperkeratotic plantar disease treated briefly",
            "Verify coverage and extend topical treatment to a pattern-appropriate course. [12][15]",
            "Do not label resistance until treatment duration and diagnosis have been reassessed. [12][15]"
          ],
          [
            "Recurrent disease with dystrophic toenails",
            "Examine for onychomycosis and address nail involvement. [12][20]",
            "Treating the nail reservoir may be necessary to control recurrent foot disease. [12][20]"
          ],
          [
            "Persistent disease despite adequate topical treatment",
            "Obtain fungal culture. [17]",
            "Confirm dermatophytosis and evaluate resistant infection or alternative diagnoses. [12][17]"
          ],
          [
            "Macerated or complicated toe webs",
            "Assess for bacterial co-infection and barrier disruption. [12][21]",
            "Manage mixed infection rather than escalating antifungal therapy alone. [12][21]"
          ],
          [
            "Recurrent cellulitis",
            "Treat tinea pedis and reinforce interdigital foot hygiene. [21]",
            "Reduce a modifiable dermatologic contributor to recurrent cellulitis. [21]"
          ]
        ]
      }
    }
  ],
  "faq": [],
  "references": [
    {
      "number": 1,
      "title": "These highlights do not include all the information needed to use Luliconazole Cream safely and effectively. See full prescribing information for Luliconazole Cream.\n      Luliconazole cream, for topical useInitial U.S. Approval: 2013",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=7ccda3ba-9c98-468d-83c6-7f0cc7c88c33",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov"
    },
    {
      "number": 2,
      "title": "[PDF] Cross Discipline Team Leader Review - FDA",
      "detail": "www.fda.gov",
      "url": "https://www.fda.gov/media/111591/download",
      "authors": "www.fda.gov",
      "host": "www.fda.gov"
    },
    {
      "number": 3,
      "title": "Inflammatory Tinea Pedis/Manuum Masquerading as Bacterial ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamapediatrics/fullarticle/204100",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 4,
      "title": "A Better Potassium Hydroxide Preparation? In Vivo Diagnosis of ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamadermatology/fullarticle/478452",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 5,
      "title": "Tinea Pedis in Children - JAMA Network",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamapediatrics/articlepdf/516240/archpedi_146_7_025.pdf?resultClick=1",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 6,
      "title": "A Better Potassium Hydroxide Preparation? - JAMA Network",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/DERM/articlepdf/478452/dob00036.pdf",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com"
    },
    {
      "number": 7,
      "title": "How effective is topical miconazole or amorolfine for mild to moderately severe onychomycosis in primary care: the Onycho Trial – a randomised double-blind placebo-controlled trial | BMJ Open",
      "detail": "bmjopen.bmj.com",
      "url": "https://bmjopen.bmj.com/content/14/5/e081914",
      "authors": "bmjopen.bmj.com",
      "host": "bmjopen.bmj.com"
    },
    {
      "number": 8,
      "title": "Dermatophyte infections - Symptoms, diagnosis and treatment",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/119",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com"
    },
    {
      "number": 9,
      "title": "Prevalence and risk factors of tinea pedis in Georgian Defense Forces",
      "detail": "militaryhealth.bmj.com",
      "url": "https://militaryhealth.bmj.com/cgi/rapidpdf/bmjmilitary-2019-001397?ijkey=0j9z8tMzFfLYqSb&keytype=ref",
      "authors": "militaryhealth.bmj.com",
      "host": "militaryhealth.bmj.com"
    },
    {
      "number": 10,
      "title": "Tinea manuum: a 5 year retrospective study of demographic data, clinical characteristics, and treatment outcomes | Scientific Reports",
      "detail": "www.nature.com",
      "url": "https://www.nature.com/articles/s41598-025-87011-w",
      "authors": "www.nature.com",
      "host": "www.nature.com"
    },
    {
      "number": 11,
      "title": "Management of tinea corporis, tinea cruris, and tinea... : Indian Dermatology Online Journal",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/idoj/fulltext/2016/07020/management_of_tinea_corporis,_tinea_cruris,_and.2.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 12,
      "title": "Toe Web Infections, the Microbiome, and Toe Web Psoriasis:...",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/aswcjournal/fulltext/2023/07000/toe_web_infections%25252C_the_microbiome%25252C_and_toe_web.8.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 13,
      "title": "Major challenges in dermatophytosis treatment : Egyptian Journal of Dermatology and Venereology",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/ejdv/fulltext/2021/41010/major_challenges_in_dermatophytosis_treatment_.1.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 14,
      "title": "Indian Association of Dermatologists,... : Indian Dermatology Online Journal",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/idoj/_layouts/15/oaks.journals/downloadpdf.aspx?an=01630814-202011040-00004",
      "authors": "journals.lww.com",
      "host": "journals.lww.com"
    },
    {
      "number": 15,
      "title": "Flexibility is warranted in applying prescribing guidelines ...",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/content/ccjom/92/9/local/complete-issue.pdf",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org"
    },
    {
      "number": 16,
      "title": "Fungal Skin Infections - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/pediatricsinreview/issue-pdf/825736",
      "authors": "publications.aap.org",
      "host": "publications.aap.org"
    },
    {
      "number": 17,
      "title": "Tinea incognito | Cleveland Clinic Journal of medicine",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/content/92/5/271",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org"
    },
    {
      "number": 18,
      "title": "Fungal Skin Infections | Pediatrics In Review - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/pediatricsinreview/article/38/1/8/35002/Fungal-Skin-Infections",
      "authors": "publications.aap.org",
      "host": "publications.aap.org"
    },
    {
      "number": 19,
      "title": "Tinea Corporis(Ringworm of the Body) - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/aapbooks/book/723/chapter/10679895/Tinea-Corporis-Ringworm-of-the-Body",
      "authors": "publications.aap.org",
      "host": "publications.aap.org"
    },
    {
      "number": 20,
      "title": "Tinea Pedis and Tinea Unguium - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/books/chapter-pdf/1297872/aap_9781581107357-part03-tinea4.pdf",
      "authors": "publications.aap.org",
      "host": "publications.aap.org"
    },
    {
      "number": 21,
      "title": "Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic P | IJGM | Dove Medical Press",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/lookup/external-ref?access_num=10.2147%2FIJGM.S326459&link_type=DOI",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org"
    },
    {
      "number": 22,
      "title": "[PDF] Guidelines on the treatment of skin and oral HIV-associated ... - IRIS",
      "detail": "iris.who.int",
      "url": "https://iris.who.int/server/api/core/bitstreams/50196a71-51c6-4e05-ade2-36e013a450fe/content",
      "authors": "iris.who.int",
      "host": "iris.who.int"
    },
    {
      "number": 23,
      "title": "[PDF] Minutes of PRAC meeting on 08-11 June 2026",
      "detail": "www.ema.europa.eu",
      "url": "https://www.ema.europa.eu/fr/media/75190",
      "authors": "www.ema.europa.eu",
      "host": "www.ema.europa.eu"
    },
    {
      "number": 24,
      "title": "Topical antifungal treatments for tinea cruris and ...",
      "detail": "www.cochranelibrary.com",
      "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009992.pub2/references",
      "authors": "www.cochranelibrary.com",
      "host": "www.cochranelibrary.com"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "These highlights do not include all the information needed to use Luliconazole Cream safely and effectively. See full prescribing information for Luliconazole Cream.\n      Luliconazole cream, for topical useInitial U.S. Approval: 2013",
      "detail": "dailymed.nlm.nih.gov",
      "url": "https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=7ccda3ba-9c98-468d-83c6-7f0cc7c88c33",
      "authors": "dailymed.nlm.nih.gov",
      "host": "dailymed.nlm.nih.gov",
      "snippet": "# 14 CLINICAL STUDIES\n\n## 14.1 Interdigital Tinea Pedis\n\nThe safety and efficacy of Luliconazole Cream, 1% was evaluated in two randomized, double-blind, vehicle-controlled, multi-center clinical trials in 423 subjects with a clinical and culture-confirmed diagnosis of interdigital tinea pedis. Subj",
      "score": 0.36643156
    },
    {
      "number": 2,
      "title": "[PDF] Cross Discipline Team Leader Review - FDA",
      "detail": "www.fda.gov",
      "url": "https://www.fda.gov/media/111591/download",
      "authors": "www.fda.gov",
      "host": "www.fda.gov",
      "snippet": "Evidence and Uncertainties Conclusions and Reasons  The clinical manifestations of tinea pedis usually present as a pruritic, erythematous, inflamed region most often seen between the toes (interdigital type) or a more severe, prolonged form that may involve the entire bottom and lateral aspects of",
      "score": 0.5504388
    },
    {
      "number": 3,
      "title": "Inflammatory Tinea Pedis/Manuum Masquerading as Bacterial ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamapediatrics/fullarticle/204100",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "The KOH preparation revealed multiple branched hyphae. A fungal culture was not obtained. He was diagnosed as having inflammatory/bullous tinea pedis and",
      "score": 0.62879556
    },
    {
      "number": 4,
      "title": "A Better Potassium Hydroxide Preparation? In Vivo Diagnosis of ...",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamadermatology/fullarticle/478452",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "A potassium hydroxide (KOH) preparation was positive for hyphae and confirmed the clinical diagnosis of tinea pedis (Figure 2A). A new imaging modality",
      "score": 0.61363083
    },
    {
      "number": 5,
      "title": "Tinea Pedis in Children - JAMA Network",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/jamapediatrics/articlepdf/516240/archpedi_146_7_025.pdf?resultClick=1",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "Moreover, patients with an unequivocally pos¬ itive KOH preparation are also unlikely to have a culture performed. Consequently, the number of children with.",
      "score": 0.38525957
    },
    {
      "number": 6,
      "title": "A Better Potassium Hydroxide Preparation? - JAMA Network",
      "detail": "jamanetwork.com",
      "url": "https://jamanetwork.com/journals/DERM/articlepdf/478452/dob00036.pdf",
      "authors": "jamanetwork.com",
      "host": "jamanetwork.com",
      "snippet": "tinea can clearly identify dermatophyte hyphae within the upper epidermis after potassium hydroxide applica- tion. The hyphae appear as bright linear branching",
      "score": 0.38498205
    },
    {
      "number": 7,
      "title": "How effective is topical miconazole or amorolfine for mild to moderately severe onychomycosis in primary care: the Onycho Trial – a randomised double-blind placebo-controlled trial | BMJ Open",
      "detail": "bmjopen.bmj.com",
      "url": "https://bmjopen.bmj.com/content/14/5/e081914",
      "authors": "bmjopen.bmj.com",
      "host": "bmjopen.bmj.com",
      "snippet": "In patients experiencing few or no symptoms, treatment might not be strictly warranted.7 12 15 For patients requiring treatment, oral terbinafine is the recommended and most effective treatment option.12 15 16 However, oral treatment can have serious adverse effects such as severe cutaneous reaction",
      "score": 0.44333586
    },
    {
      "number": 8,
      "title": "Dermatophyte infections - Symptoms, diagnosis and treatment",
      "detail": "bestpractice.bmj.com",
      "url": "https://bestpractice.bmj.com/topics/en-us/119",
      "authors": "bestpractice.bmj.com",
      "host": "bestpractice.bmj.com",
      "snippet": "open menu\n\nAo visualizar este tópico em um idioma diferente, você poderá notar algumas diferenças na forma como o conteúdo é estruturado, mas ele ainda refletirá as orientações baseadas em evidências mais recentes.\n\n# Dermatophyte infections\n\nEpidemiology\n\nEtiology\n\nCase history\n\nApproach\n\nHistory a",
      "score": 0.36908817
    },
    {
      "number": 9,
      "title": "Prevalence and risk factors of tinea pedis in Georgian Defense Forces",
      "detail": "militaryhealth.bmj.com",
      "url": "https://militaryhealth.bmj.com/cgi/rapidpdf/bmjmilitary-2019-001397?ijkey=0j9z8tMzFfLYqSb&keytype=ref",
      "authors": "militaryhealth.bmj.com",
      "host": "militaryhealth.bmj.com",
      "snippet": "As tinea pedis has a contagious and recurrent nature, this pathology is the most common disease in dermatomycosis. For this reason, it",
      "score": 0.36629558
    },
    {
      "number": 10,
      "title": "Tinea manuum: a 5 year retrospective study of demographic data, clinical characteristics, and treatment outcomes | Scientific Reports",
      "detail": "www.nature.com",
      "url": "https://www.nature.com/articles/s41598-025-87011-w",
      "authors": "www.nature.com",
      "host": "www.nature.com",
      "snippet": "Routinely, for patients with suspected fungal hand infection, microscopic examination with 20% potassium hydroxide (KOH) preparations from suspected lesions was performed to confirm fungal infection. Patients who were positive for branching septate hyphae on the KOH examination were included in the ",
      "score": 0.38110495
    },
    {
      "number": 11,
      "title": "Management of tinea corporis, tinea cruris, and tinea... : Indian Dermatology Online Journal",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/idoj/fulltext/2016/07020/management_of_tinea_corporis,_tinea_cruris,_and.2.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Tinea pedis is usually treated with a topical antifungal cream for 4 weeks; interdigital tinea pedis may only require 1 week of therapy. Various topical antifungal effective against tinea pedis include azoles, allylamines, butenafine, ciclopirox, tolnaftate, and amorolfine as evidenced by a meta-ana",
      "score": 0.67347145
    },
    {
      "number": 12,
      "title": "Toe Web Infections, the Microbiome, and Toe Web Psoriasis:...",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/aswcjournal/fulltext/2023/07000/toe_web_infections%25252C_the_microbiome%25252C_and_toe_web.8.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Refractory toe web infection can result from inadequate treatment, antifungal or antibiotic resistance, nail involvement, and immune deficiency. Urea cream may be useful in preventing recurrent tinea pedis if thick, plantar skin is the reservoir, although thin toe web skin would necessitate a lower ",
      "score": 0.4766533
    },
    {
      "number": 13,
      "title": "Major challenges in dermatophytosis treatment : Egyptian Journal of Dermatology and Venereology",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/ejdv/fulltext/2021/41010/major_challenges_in_dermatophytosis_treatment_.1.aspx",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "Due to the few antifungal drugs available to treat dermatophyte infections, some strategies must become the focus of attention as traditional drug modification, developing modern formulas of antifungal agents and antifungal drug combinations to get synergic action against dermatophytosis.\n\nAntifunga",
      "score": 0.38824743
    },
    {
      "number": 14,
      "title": "Indian Association of Dermatologists,... : Indian Dermatology Online Journal",
      "detail": "journals.lww.com",
      "url": "https://journals.lww.com/idoj/_layouts/15/oaks.journals/downloadpdf.aspx?an=01630814-202011040-00004",
      "authors": "journals.lww.com",
      "host": "journals.lww.com",
      "snippet": "19. Sardana K, Khurana ASardana K, Khurana A. Overview of causes and treatment of recalcitrant dermatophytosis IADVL Manual on Management of Dermatophytosis. 20181st ed New Delhi CBS Publishers & distributors:80–104Cited Here \n   20. Shivanna R, Inamadar AC. Clinical failure of antifungal therapy of",
      "score": 0.38435796
    },
    {
      "number": 15,
      "title": "Flexibility is warranted in applying prescribing guidelines ...",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/content/ccjom/92/9/local/complete-issue.pdf",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org",
      "snippet": "530 CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 92 • NUMBER 9 SEPTEMBER 2025 TINEA PEDIS Differential diagnosis The differential diagnosis of plantar erythema includes intertrigo, cellulitis, atopic dermatitis, contact derma-titis, eczema, juvenile plantar dermatosis, mycosis fun-goides, and pityria",
      "score": 0.75181264
    },
    {
      "number": 16,
      "title": "Fungal Skin Infections - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/pediatricsinreview/issue-pdf/825736",
      "authors": "publications.aap.org",
      "host": "publications.aap.org",
      "snippet": "Tinea pedis. 8. Pediatrics in Review. Page 13. differential diagnosis and methods for confirming diagnosis based on clinical presentation are discussed.",
      "score": 0.6033015
    },
    {
      "number": 17,
      "title": "Tinea incognito | Cleveland Clinic Journal of medicine",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/content/92/5/271",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org",
      "snippet": "### Diagnosis and treatment\n\nThe 2 key issues in managing tinea incognito are proper diagnosis and prevention. Diagnosis can be delayed because of the atypical appearance of the lesions, but careful examination for scaly erythematous edges aids in identification. Although newer diagnostic modalities",
      "score": 0.5100334
    },
    {
      "number": 18,
      "title": "Fungal Skin Infections | Pediatrics In Review - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/pediatricsinreview/article/38/1/8/35002/Fungal-Skin-Infections",
      "authors": "publications.aap.org",
      "host": "publications.aap.org",
      "snippet": "This article reviews the epidemiology and clinical presentations of tinea infections (capitis, corporis, pedis, cruris, unguium), PV, and MC in",
      "score": 0.36161602
    },
    {
      "number": 19,
      "title": "Tinea Corporis(Ringworm of the Body) - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/aapbooks/book/723/chapter/10679895/Tinea-Corporis-Ringworm-of-the-Body",
      "authors": "publications.aap.org",
      "host": "publications.aap.org",
      "snippet": "The differential diagnosis for tinea corporis includes pityriasis rosea herald patch), candidiasis, psoriasis, other dermatitides",
      "score": 0.35287103
    },
    {
      "number": 20,
      "title": "Tinea Pedis and Tinea Unguium - AAP Publications",
      "detail": "publications.aap.org",
      "url": "https://publications.aap.org/books/chapter-pdf/1297872/aap_9781581107357-part03-tinea4.pdf",
      "authors": "publications.aap.org",
      "host": "publications.aap.org",
      "snippet": "Tinea pedis that is severe, chronic, or refractory to topical treatment may be treated with oral therapy. Oral itraconazole or terbinafine is the most",
      "score": 0.34514993
    },
    {
      "number": 21,
      "title": "Recurrent Cellulitis: Who is at Risk and How Effective is Antibiotic P | IJGM | Dove Medical Press",
      "detail": "www.ccjm.org",
      "url": "https://www.ccjm.org/lookup/external-ref?access_num=10.2147%2FIJGM.S326459&link_type=DOI",
      "authors": "www.ccjm.org",
      "host": "www.ccjm.org",
      "snippet": "Individuals with associated tinea pedis should be educated on foot hygiene with attention to the interdigital webbings of the toes.62 The use of topical or systemic antifungal agents may be needed to control recurrent tinea pedis despite adequate foot hygiene.78\n\n### Systemic Factors\n\nIn patients wi",
      "score": 0.24888588
    },
    {
      "number": 22,
      "title": "[PDF] Guidelines on the treatment of skin and oral HIV-associated ... - IRIS",
      "detail": "iris.who.int",
      "url": "https://iris.who.int/server/api/core/bitstreams/50196a71-51c6-4e05-ade2-36e013a450fe/content",
      "authors": "iris.who.int",
      "host": "iris.who.int",
      "snippet": "units/ml), 4–6 ml QID 7–14 days 0.0336/ml Clotrimazole troches 10 mg PO 5 times daily 7–14 days 1.207 (10 mg troche) Itraconazole 200 mg solution OD 28 days for esophageal candidiasis resistant to fluconazole 0.94/mg (150 ml of 10 mg/ml solutions costs US$142) 86 Guidelines on the treatment of skin ",
      "score": 0.6180666
    },
    {
      "number": 23,
      "title": "[PDF] Minutes of PRAC meeting on 08-11 June 2026",
      "detail": "www.ema.europa.eu",
      "url": "https://www.ema.europa.eu/fr/media/75190",
      "authors": "www.ema.europa.eu",
      "host": "www.ema.europa.eu",
      "snippet": "floccosum; the treatment of ringworm (i.e., tinea corporis, tinea cruris and tinea pedis) where oral therapy is considered appropriate due to the site, severity or extent of the infection; and the treatment of onychomycosis. Topical terbinafine is indicated for the treatment of fungal infections of ",
      "score": 0.5053471
    },
    {
      "number": 24,
      "title": "Topical antifungal treatments for tinea cruris and ...",
      "detail": "www.cochranelibrary.com",
      "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009992.pub2/references",
      "authors": "www.cochranelibrary.com",
      "host": "www.cochranelibrary.com",
      "snippet": "Terbinafine (1%) solution and emulsion gel: two new formulations in one week treatment of tinea pedis and tinea corporis/cruris (Abstract P218). The 7th ...Read more",
      "score": 0.4905535
    }
  ],
  "publishedAt": "2026-09-15T23:54:02.632388+00:00",
  "updatedAt": "2026-09-15T23:54:02.632388+00:00",
  "readingMinutes": 5,
  "slug": "tinea-pedis"
}